| Cash Flow | 2025-09-30 |
|---|---|
| Net income from continuing operations | 149,596 |
| Provision for credit losses | 75,621 |
| Depreciation and amortization | 29,179 |
| Share-based compensation expense | 13,063 |
| Deferred taxes | -12,703 |
| Net amortization (accretion) of investment securities premiums and discounts | 2,958 |
| Unrealized (gain) loss on investment securities | 307 |
| Impairment loss on debt securities | -51,319 |
| Impairment loss on equity securities | 2,278 |
| Net (gain) loss on sale of investment securities | -1,611 |
| Unrealized gain on equity method investments | 0 |
| Unrealized (gain) loss on derivatives | 1,884 |
| (gain) loss on sale of leased assets under lessor operating leases | 1,857 |
| Fair value adjustment on loans held for sale | -486 |
| Fair value adjustment on loans held for investment | 2,278 |
| Net (gain) loss on sale of loans and leases | 2 |
| Origination and purchases of loans held for sale | 606,180 |
| Proceeds from the sales and repayments of loans held for sale | 672,239 |
| Amortization (accretion) of loan net deferred fees, discounts and premiums | -27,962 |
| Earnings on investment in bank-owned life insurance | 9,074 |
| (increase) decrease in accrued interest receivable and other assets | -6,528 |
| Increase (decrease) in accrued interest payable and other liabilities | 36,474 |
| Net cash provided by (used in) operating activities | 373,189 |
| Proceeds from maturities, calls and principal repayments of investment securities available for sale | 246,168 |
| Proceeds from maturities, calls and principal repayments of investment securities held to maturity | 218,611 |
| Proceeds from sales of investment securities available for sale | 551,337 |
| Purchases of investment securities available for sale | 802,476 |
| Purchases of investment securities held to maturity | 24,005 |
| Purchases of equity method investments | 0 |
| Origination of mortgage finance loans | 19,265,031 |
| Proceeds from repayments of mortgage finance loans | 19,120,445 |
| Net (increase) decrease in loans and leases, excluding mortgage finance loans | 1,264,353 |
| Proceeds from sales of loans and leases | 1,081 |
| Purchases of loans | 334,886 |
| Purchases of bank-owned life insurance | 1,462 |
| Proceeds from bank-owned life insurance | 5,634 |
| Net purchases from sale of fhlb, federal reserve bank, and other restricted stock | 7,076 |
| Purchases of bank premises and equipment | 11,250 |
| Proceeds from sale of other real estate owned | 118 |
| Proceeds from sales of leased assets under lessor operating leases | 11,091 |
| Purchases of leased assets under lessor operating leases | 88,809 |
| Net cash provided by (used in) investing activities | -1,644,863 |
| Net increase (decrease) in deposits | 1,530,025 |
| Net increase (decrease) in short-term borrowed funds from fhlb | -50,000 |
| Proceeds from long-term borrowed funds from fhlb and frb | 310,000 |
| Repayments of long-term borrowed funds from fhlb and frb | 200,000 |
| Repayments of other long-term borrowings | 0 |
| Redemption of preferred stock | 57,501 |
| Preferred stock dividends paid | 8,855 |
| Purchase of treasury stock | 5,641 |
| Payments of employee taxes withheld from share-based awards | 12,534 |
| Proceeds from issuance of common stock | 165,888 |
| Net cash provided by (used in) financing activities | 1,671,382 |
| Net increase (decrease) in cash and cash equivalents | 399,708 |
| Cash and cash equivalents at beginning of period | 3,785,931 |
| Cash and cash equivalents at end of period | 4,185,639 |
Customers Bancorp, Inc. (CUBI-PF)
Customers Bancorp, Inc. (CUBI-PF)